Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis
- 11Precigen, Inc. Germantown, MD , USA
- 2Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
- 3Precigen, Inc., Germantown, MD, USA
Related
- Allergen Immunotherapy and 36‐Month Allergic Respiratory Disease Trajectories: A Target‐Trial
- 47 AI-assisted cytometry panel design for cancer immunotherapy
- Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting
- Exploring tumor-derived exosomes as promising antigenic platforms: novel vaccine and immunotherapy strategies for “cold” colorectal cancer
- CAR-macrophage immunotherapy targeting fibroblast-like synoviocytes ameliorates inflammatory and degenerative arthritis
BibTeX
@article{sabzevari2026zopapogene,
title = {{524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis}},
author = {Helen Sabzevari and Amy Lankford and Gaetano Bonifacio and Scott M Norberg and Roshanak T Semnani and Tasha B Tan and David M Dalton and Premkumar V Giridhar and Clint T Allen},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0524},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0524},
note = {CC BY},
}
RIS
TY - JOUR
TI - 524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis
AU - Helen Sabzevari
AU - Amy Lankford
AU - Gaetano Bonifacio
AU - Scott M Norberg
AU - Roshanak T Semnani
AU - Tasha B Tan
AU - David M Dalton
AU - Premkumar V Giridhar
AU - Clint T Allen
PY - 2026
DA - 2026/11/04
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0524
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0524
SN - 2051-1426
ER -